• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特阿拉伯西南部阿巴市 2 型糖尿病患者中的非酒精性脂肪性肝病。

Non-Alcoholic Fatty Liver Disease among Type-2 Diabetes Mellitus Patients in Abha City, South Western Saudi Arabia.

机构信息

Department of Family and Community Medicine, College of Medicine, King Khalid University, P.O. Box 641, Abha 61421, Saudi Arabia.

Department of Epidemiology, High Institute of Public Health, Alexandria University, Alexandria 21511, Egypt.

出版信息

Int J Environ Res Public Health. 2018 Nov 11;15(11):2521. doi: 10.3390/ijerph15112521.

DOI:10.3390/ijerph15112521
PMID:30423871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6266142/
Abstract

The objective of this study was to determine the prevalence and the factors associated with non-alcoholic fatty liver disease (NAFLD) among type-2 diabetes mellitus (T2DM) patients in Abha City, Southwestern Saudi Arabia. Using a cross-sectional study design, a representative sample of 245 T2DM patients were recruited from all primary healthcare centers in Abha city. A detailed medical history as well as laboratory investigations were done. NAFLD was diagnosed using abdominal ultrasound examination. The overall prevalence of NAFLD was 72.8% (95% CI: 66.6%⁻78.1%). In a multivariable regression analysis, the risk of NAFLD was significantly higher among overweight T2DM patients (aOR = 6.112, 95% CI: 1.529⁻4.432), Obese (aOR = 10.455, 95% CI: 2.645⁻41.326), with high ALT of more than 12 IU/L (aOR = 2.335, 95% CI: 1.096⁻5.062), moderate diet-compliant patients (aOR = 2.413, 95% CI: 1.003⁻5.805) and poor diet-compliant patients (aOR = 6.562, 95% CI: 2.056⁻20.967). On the other hand, high HDL (high density cholesterol) (in mg/dL) was a protective factor for NAFLD (aOR = 0.044, 95% CI: 0.005⁻0.365). It was concluded that NAFLD is a common association of T2DM. Increasing BMI (Body mass index), lower HDL level, and poor dietary control are significant factors associated with NAFLD among T2DM patients. Health education to improve dietary control and avoid excessive weight gain, testing for NAFLD among diabetic patients, especially those with abnormal BMI and HDL, are recommended for early detection and to ensure optimal levels of HDL.

摘要

本研究旨在确定沙特阿拉伯西南部阿巴市 2 型糖尿病(T2DM)患者中非酒精性脂肪性肝病(NAFLD)的患病率及其相关因素。采用横断面研究设计,从阿巴市所有初级保健中心招募了 245 名 T2DM 患者的代表性样本。进行了详细的病史和实验室检查。使用腹部超声检查诊断 NAFLD。NAFLD 的总体患病率为 72.8%(95%CI:66.6%-78.1%)。在多变量回归分析中,超重 T2DM 患者(aOR=6.112,95%CI:1.529-4.432)、肥胖(aOR=10.455,95%CI:2.645-41.326)、丙氨酸转氨酶(ALT)高于 12IU/L 的患者(aOR=2.335,95%CI:1.096-5.062)、中度饮食依从性患者(aOR=2.413,95%CI:1.003-5.805)和饮食依从性差的患者(aOR=6.562,95%CI:2.056-20.967)发生 NAFLD 的风险显著更高。另一方面,较高的高密度脂蛋白(HDL)(mg/dL)是 NAFLD 的保护因素(aOR=0.044,95%CI:0.005-0.365)。研究结论为,NAFLD 是 T2DM 的常见合并症。BMI(体重指数)增加、HDL 水平降低和饮食控制不良是 T2DM 患者中与 NAFLD 相关的重要因素。建议对糖尿病患者,尤其是 BMI 和 HDL 异常的患者,进行 NAFLD 检测,开展健康教育以改善饮食控制和避免体重过度增加,从而实现 NAFLD 的早期发现并确保 HDL 水平处于最佳状态。

相似文献

1
Non-Alcoholic Fatty Liver Disease among Type-2 Diabetes Mellitus Patients in Abha City, South Western Saudi Arabia.沙特阿拉伯西南部阿巴市 2 型糖尿病患者中的非酒精性脂肪性肝病。
Int J Environ Res Public Health. 2018 Nov 11;15(11):2521. doi: 10.3390/ijerph15112521.
2
Hepatitis C Virus Infection at Primary Healthcare Level in Abha City, Southwestern Saudi Arabia: Is Type 2 Diabetes Mellitus an Associated Factor?沙特阿拉伯西南部阿巴市基层医疗水平的丙型肝炎病毒感染:2 型糖尿病是否为相关因素?
Int J Environ Res Public Health. 2018 Nov 9;15(11):2513. doi: 10.3390/ijerph15112513.
3
Clinical and Biochemical Predictors of Nonalcoholic Fatty Liver Disease among Type 2 Diabetes Mellitus Patients at Primary Health Care Level in South Western Saudi Arabia.沙特阿拉伯西南部基层医疗水平的2型糖尿病患者中非酒精性脂肪性肝病的临床和生化预测指标
Diagnostics (Basel). 2020 Oct 12;10(10):809. doi: 10.3390/diagnostics10100809.
4
Gender-specific association between non-alcoholic fatty liver disease and type 2 diabetes mellitus among a middle-aged and elderly Chinese population: An observational study.非酒精性脂肪性肝病与中老年人群 2 型糖尿病的性别相关性:一项观察性研究。
Medicine (Baltimore). 2021 Feb 12;100(6):e24743. doi: 10.1097/MD.0000000000024743.
5
Non alcoholic fatty liver disease in a Nigerian population with type II diabetes mellitus.尼日利亚II型糖尿病患者中的非酒精性脂肪性肝病
Pan Afr Med J. 2016 May 6;24:20. doi: 10.11604/pamj.2016.24.20.8181. eCollection 2016.
6
Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus.非酒精性脂肪性肝病在糖尿病患者中的临床谱。
PLoS One. 2020 Aug 21;15(8):e0236977. doi: 10.1371/journal.pone.0236977. eCollection 2020.
7
Non-obese or lean non-alcoholic fatty liver disease was associated with increased risk of cancer in patients with type 2 diabetes mellitus.非肥胖或非消瘦的非酒精性脂肪性肝病与 2 型糖尿病患者的癌症风险增加相关。
BMJ Open Diabetes Res Care. 2023 Feb;11(1). doi: 10.1136/bmjdrc-2022-003066.
8
Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.肥胖与非酒精性脂肪性肝病对2型糖尿病发病率影响的比较。
World J Gastroenterol. 2015 Aug 28;21(32):9607-13. doi: 10.3748/wjg.v21.i32.9607.
9
Serum Ferritin level, microalbuminuria and non-alcoholic fatty liver disease in type 2 diabetic patients.2型糖尿病患者的血清铁蛋白水平、微量白蛋白尿与非酒精性脂肪性肝病
Diabetes Metab Syndr. 2019 May-Jun;13(3):2226-2229. doi: 10.1016/j.dsx.2019.05.030. Epub 2019 May 25.
10
Lean non-alcoholic fatty liver disease and associated metabolic disturbance: A Saudi Arabian cross-sectional study.非酒精性脂肪肝和相关代谢紊乱:沙特阿拉伯的一项横断面研究。
Physiol Rep. 2021 Jul;9(14):e14949. doi: 10.14814/phy2.14949.

引用本文的文献

1
Assessing Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Patients at a Tertiary Hospital, Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴一家三级医院对2型糖尿病患者的非酒精性脂肪性肝病评估。
J Diabetes Res. 2025 Aug 23;2025:5555842. doi: 10.1155/jdr/5555842. eCollection 2025.
2
A systematic review of obesity burden in Saudi Arabia: Prevalence and associated co-morbidities.沙特阿拉伯肥胖负担的系统评价:患病率及相关合并症
Saudi Pharm J. 2024 Nov;32(11):102192. doi: 10.1016/j.jsps.2024.102192. Epub 2024 Oct 24.
3
Assessment of Liver Involvement in Patients With Type 2 Diabetes Mellitus in Basrah City, Iraq, Using FibroScan and Correlation With Risk Factors.使用FibroScan评估伊拉克巴士拉市2型糖尿病患者的肝脏受累情况及其与危险因素的相关性。
Cureus. 2024 Jul 22;16(7):e65089. doi: 10.7759/cureus.65089. eCollection 2024 Jul.
4
Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) Among Diabetic Mellitus Patients in Saudi Arabia: Systematic Review and Meta-Analysis.沙特阿拉伯糖尿病患者中非酒精性脂肪性肝病(NAFLD)的患病率:系统评价与荟萃分析
Cureus. 2023 Dec 25;15(12):e51092. doi: 10.7759/cureus.51092. eCollection 2023 Dec.
5
The epidemiology and characteristics of patients with diabetes with or without NASH: a systematic review.伴有或不伴有 NASH 的糖尿病患者的流行病学和特征:一项系统综述。
Afr Health Sci. 2023 Jun;23(2):509-518. doi: 10.4314/ahs.v23i2.59.
6
Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Saudi Arabia: Systematic Review and Meta-analysis.沙特阿拉伯非酒精性脂肪性肝病(NAFLD)的患病率:系统评价与荟萃分析
Cureus. 2023 Jun 12;15(6):e40308. doi: 10.7759/cureus.40308. eCollection 2023 Jun.
7
Exploring the Validity of Available Markers and Indices in the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) in People with Type 2 Diabetes in Saudi Arabia.探索沙特阿拉伯2型糖尿病患者中非酒精性脂肪性肝病(NAFLD)诊断中现有标志物和指标的有效性。
Diseases. 2023 Jan 15;11(1):10. doi: 10.3390/diseases11010010.
8
Higher carbohydrate intake in relation to non-alcoholic fatty liver disease in patients with type 2 diabetes.2型糖尿病患者碳水化合物摄入量与非酒精性脂肪性肝病的关系
Front Nutr. 2022 Dec 8;9:996004. doi: 10.3389/fnut.2022.996004. eCollection 2022.
9
Dietary total antioxidant capacity is inversely associated with the odds of non-alcoholic fatty liver disease in people with type-2 diabetes.饮食中的总抗氧化能力与2型糖尿病患者患非酒精性脂肪性肝病的几率呈负相关。
Front Nutr. 2022 Nov 3;9:1037851. doi: 10.3389/fnut.2022.1037851. eCollection 2022.
10
Association between serum uric acid-to-creatinine ratio and non-alcoholic fatty liver disease: a cross-sectional study in Chinese non-obese people with a normal range of low-density lipoprotein cholesterol.血清尿酸肌酐比值与非酒精性脂肪肝的关系:一项在中国非肥胖且 LDL 胆固醇正常范围内人群的横断面研究。
BMC Gastroenterol. 2022 Sep 14;22(1):419. doi: 10.1186/s12876-022-02500-w.

本文引用的文献

1
Prevalence and associations of non-alcoholic fatty liver disease (NAFLD) in Sri Lankan patients with type 2 diabetes: A single center study.斯里兰卡2型糖尿病患者中非酒精性脂肪性肝病(NAFLD)的患病率及相关性:一项单中心研究。
Diabetes Metab Syndr. 2019 Jan-Feb;13(1):246-250. doi: 10.1016/j.dsx.2018.09.002. Epub 2018 Sep 8.
2
The Relationship Between Glycaemic Control and Non-Alcoholic Fatty Liver Disease in Nigerian Type 2 Diabetic Patients.尼日利亚 2 型糖尿病患者血糖控制与非酒精性脂肪肝的关系。
J Natl Med Assoc. 2018 Jun;110(3):256-264. doi: 10.1016/j.jnma.2017.06.001. Epub 2017 Jun 27.
3
Glycated albumin in chronic kidney disease: Pathophysiologic connections.慢性肾脏病中的糖化白蛋白:病理生理联系
Diabetes Metab Syndr. 2018 May;12(3):463-468. doi: 10.1016/j.dsx.2018.01.002. Epub 2018 Feb 1.
4
Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: A meta-analysis.2型糖尿病患者中非酒精性脂肪性肝病的患病率:一项荟萃分析。
Medicine (Baltimore). 2017 Sep;96(39):e8179. doi: 10.1097/MD.0000000000008179.
5
Prevalence of Non Alcoholic Fatty Liver Disease and its Association with Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus.2型糖尿病患者中非酒精性脂肪性肝病的患病率及其与糖尿病肾病的关联
J Clin Diagn Res. 2017 May;11(5):OC04-OC07. doi: 10.7860/JCDR/2017/25931.9823. Epub 2017 May 1.
6
Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: Evidence from the Dongfeng-Tongji cohort study.中国人群中非酒精性脂肪性肝病与2型糖尿病的双向关联:来自东风-同济队列研究的证据。
PLoS One. 2017 Mar 28;12(3):e0174291. doi: 10.1371/journal.pone.0174291. eCollection 2017.
7
The Burden of NAFLD and Its Characteristics in a Nationwide Population with Type 2 Diabetes.全国2型糖尿病患者中NAFLD的负担及其特征
J Diabetes Res. 2016;2016:2931985. doi: 10.1155/2016/2931985. Epub 2016 Mar 30.
8
EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.欧洲肝脏研究学会(EASL)-欧洲糖尿病研究学会(EASD)-欧洲肥胖症研究学会(EASO)非酒精性脂肪性肝病管理临床实践指南
Obes Facts. 2016;9(2):65-90. doi: 10.1159/000443344. Epub 2016 Apr 8.
9
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.全球非酒精性脂肪性肝病流行病学——患病率、发病率和结局的荟萃分析评估。
Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22.
10
Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的诊断、肝活检转诊及治疗建议
Mayo Clin Proc. 2015 Sep;90(9):1233-46. doi: 10.1016/j.mayocp.2015.06.013. Epub 2015 Jul 26.